originally published Thursday, January 11, 2018

Printable Version

All Biotech & Medical Stocks

Audioeye released excellent results today which indicate that the company is on its way at last. Initially the stock blasted higher on this news, surging to $.27, but was immediately beaten back down by a wall of overhanging supply, so that it is now, at the time of writing, only up about 13% and looks set to close with an “Inverted Hammer” candlestick on its chart. At first sight this apparent inability to hold a gain might be construed as bearish, but it is not – the turnaround and drop is caused by a lot of pre-existing sell orders that have not been cancelled, usually because the investors who have placed them are not yet aware of the good news, or even if they are, are disillusioned with the stock and inclined to sell. Thus, when a large example of this type of candle appears on the chart, especially on strong volume, it is followed by a sustained advance.

Audioeye is therefore rated an immediate strong buy ideally before the close today.

AudioEye Inc website

AudioEye Inc AEYE on OTC, trading at $0.19 at 3.20 pm EST on 11th January 18.

Posted at 3.35 pm EST on 11th January 18.

The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stockmarket analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.